Once-daily crisaborole as a long-term maintenance treatment in participants with mild-to-moderate atopic dermatitis: a 52-week clinical trial
ACTA DERMATO-VENEREOLOGICA(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ACTA DERMATO-VENEREOLOGICA(2022)